Home    Back

Lu aa24493    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
18Spinocerebellar degeneration3

18. Spinocerebellar degeneration    [ 59 clinical trials,   78 drugs,   (DrugBank: 28 drugs),   44 drug target genes,   59 drug target pathways]
Searched query = "Spinocerebellar degeneration", "SCD", "Spinocerebellar ataxia type I", "SCA1", "Spinocerebellar ataxia type II", "SCA2", "Spinocerebellar ataxia type III", "SCA3", "Machado-Joseph disease", "Spinocerebellar ataxia type VI", "SCA6", "Spinocerebellar ataxia type VII", "SCA7", "Spinocerebellar ataxia type X", "SCA10", "Spinocerebellar ataxia type XII", "SCA12", "Dentatorubural pallidoluysian atrophy", "Dentatorubropallidoluysial atrophy", "DRPLA", "Naito-Koyanagi disease", "Friedreich ataxia", "FRDA", "Ataxia with vitamin E deficiency", "AVED", "Early-onset ataxia with ocular motor ataxia and hypoalbuminemia", "EOAH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 59 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2008-003662-25-IT
(EUCTR)		21/10/200901/10/2009Studio randomizzato, in doppio cieco, controllato verso placebo, per valutare la sicurezza e la tollerabilita` e per esplorare l efficacia di Lu AA24493, in pazienti con Atassia di Friedreich - NDStudio randomizzato, in doppio cieco, controllato verso placebo, per valutare la sicurezza e la tollerabilita` e per esplorare l efficacia di Lu AA24493, in pazienti con Atassia di Friedreich - ND Friedreich`s Ataxia (FRDA)
MedDRA version: 9.1;Level: LLT;Classification code 10017374		Product Name: Lu AA24493
Product Code: Lu AA24493		H.Lundbeck A/SNULLNot RecruitingFemale: yes
Male: yes		36Germany;Italy;Austria
2EUCTR2008-003662-25-AT
(EUCTR)		02/10/200914/08/2009Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacyRandomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy Friedreich's Ataxia (FRDA)
MedDRA version: 12.0;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia		Product Name: Lu AA24493
Product Code: Lu AA24493 		H. Lundbeck A/SNULLNot RecruitingFemale: yes
Male: yes		36Germany;Italy;Austria
3EUCTR2008-003662-25-DE
(EUCTR)		21/08/2009Randomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacyRandomised, double blind, placebo controlled study of Lu AA24493 in patients with Friedreich's Ataxia to evaluate safety and tolerability and to explore efficacy Friedreich's Ataxia (FRDA)
MedDRA version: 12.0;Level: LLT;Classification code 10017374;Term: Friedreich's ataxia		Product Name: Lu AA24493
Product Code: Lu AA24493 		H. Lundbeck A/SNULLNot RecruitingFemale: yes
Male: yes		36Austria;Germany;Italy